Help Fight OCD By Participating In a CLINICAL TRIAL
Dr. Luca Cocchi, Professor Michael Breakspear
Obsessive Compulsive Disorder (OCD) affects around 2% of the Australian population. The symptoms and features of OCD can vary greatly. The causes are not fully understood, but it is likely a combination of lifestyle and biological factors.
Researchers are testing a new intervention for OCD symptoms. The trial involves use of transcranial magnetic stimulation (TMS). It allows for the safe and non-invasive adjustment of brain activity. The trial aims to assess whether TMS can be used to improve OCD symptoms.
This study seeks men and women between the ages of 18 and 50 who have been diagnosed with OCD for at least 12 months. Participants are required to attend 24 study site visits over 6 weeks, along with a 25th 6 month follow up visit, and will be helping advance medical research. Participants will be offered parking/transport vouchers (up to 40 AUD per visit).
Benefits to Participation
- We cannot guarantee or promise that you will receive any benefits from this research. However, possible benefits may include a reduction in OCD. Please note that this effect remains hypothetical and has not yet been established by scientific research. Please also note that you may be part of the control TMS group, who will receive a placebo stimulation that will not change your brain activity.
- You will be helping advance OCD research.
- Participation is completely voluntary
- If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time without affecting any future health care
- Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
- Qualified health professionals will monitor your health as it relates to the study.
Who Can Participate?
- Men and women between the ages of 18 and 50 years old.
- Have had an OCD diagnosis for a period longer than 12 months.
- Are able to attend 24 visits at the study site in Brisbane within a period of approximately 6 weeks, with a 25th follow up visit 6 months later
This clinicai trial has been reviewed and approved by the RBWH Human Research Ethics Committee (EC00172) and the QIMR Berghofer Medical Research Institute Human Research Ethics Committee (EC00278)
How can I participate?
If you are interested in participating, please email firstname.lastname@example.org or contact Dr Luca Cocchi, Lead Principal Investigator on 07 3845 3008.